first generation glp 1 GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH How are GLP-1 drugs impacting

Table of Contents Understanding GLP-1 therapy in virtual care Key monitoring parameters for remote initiation Patient education and adherence strategies Addressing risks and optimizing outcomes Understanding GLP-1 Therapy in Virtual Care GLP-1 receptor agonists have transformed the management of type 2 diabetes and obesity

doi: 10.2337/dci17-0057 [DOI] [PMC free article] [PubMed] [Google Scholar] 224

The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease

Antiemetics such as ondansetron, dexamethasone, aprepitant, and diphenhydramine should be considered

Soups and chilis portion into individual containers and thaw overnight

Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist